[1]王登坤,第五永长,苟于瑞,等.基于糖脂代谢探讨肠道微生物组与阿尔茨海默病的关系[J].陕西医学杂志,2025,54(4):565-570.[doi:DOI:10.3969/j.issn.1000-7377.2025.04.026]
　WANG Dengkun,DI WU Yongchang,GOU Yurui,et al.Discussing the link between gut microbiome and Alzheimer's disease based on glucose and lipid metabolism[J].,2025,54(4):565-570.[doi:DOI:10.3969/j.issn.1000-7377.2025.04.026]
点击复制

基于糖脂代谢探讨肠道微生物组与阿尔茨海默病的关系
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年4期
页码:
565-570
栏目:
综 述
出版日期:
2025-04-05

文章信息/Info

Title:
Discussing the link between gut microbiome and Alzheimer's disease based on glucose and lipid metabolism
作者:
王登坤1; 第五永长1; 2; 苟于瑞3; 熊 鹏1
(1.陕西中医药大学附属医院,陕西 咸阳 712077; 2.陕西中医药大学,陕西 咸阳 712046; 3.西电集团医院,陕西 西安 710077)
Author(s):
WANG Dengkun1; DI WU Yongchang1; 2; GOU Yurui3; XIONG Peng1
(1. Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine,Xianyang 712077,China; 2.Shaanxi University of Chinese Medicine,Xianyang 712046,China; 3.Xidian Group Hospital,Xi'an 710077,China)
关键词:
阿尔茨海默病;  糖代谢;  脂质代谢;  脑代谢;  代谢紊乱;  肠道微生物
Keywords:
Alzheimer's disease;  Glucose metabolism;  Lipid metabolism;  Brain metabolism;  Metabolic disorders;  Gut microbes
分类号:
R 743
DOI:
DOI:10.3969/j.issn.1000-7377.2025.04.026
文献标志码:
A
摘要:
阿尔茨海默病(AD)是一种进行性记忆障碍和认知功能下降为主要表现的神经退行性疾病,目前发病机制尚不明确。已有研究表明AD可能是一种代谢性疾病,与糖脂代谢密切相关。随着微生物-肠-脑轴学说的兴起,肠道菌群与AD关系的研究逐渐成为近年来的研究热点,而肠道菌群又可显著调节机体糖脂代谢水平,故本文综述AD、糖脂代谢及肠道菌群三者之间的关系,旨在为肠道菌群经代谢途径影响AD提供理论基础,为AD发病机制的未来研究提供新的思路。
Abstract:
Alzheimer's disease(AD)is a neurodegenerative disease mainly manifested by memory and cognitive dysfunction,and its pathogenesis is still unclear.Studies have shown that AD may be a metabolic disease,which is closely related to glucose and lipid metabolism.With the rise of the microbe-gut-brain axis theory,gut microbiota and AD have gradually become research hotspots in recent years,and gut microbiota can significantly regulate the level of glucose and lipid metabolism in the body.Therefore,this article reviews AD,glucose and lipid metabolism and The relationship between the three gut microbiota aims to provide a theoretical basis for the influence of gut microbiota on AD through metabolic pathways,and to provide new ideas for future research on the pathogenesis of AD.

参考文献/References:

[1] SCHELTENS P,STROOPER B D,KIVIPELTO M,et al.Alzheimer's disease[J].The Lancet,2021,397(10284):1577-1590.
[2] CANDASAMY M,ELHASSAN S A M,BHATTAMISRA S K,et al.Type 3 diabetes(Alzheimer's disease):New insight for promising therapeutic avenues[J].Panminerva medica,2020,62(3):155-163.
[3] YIN F.Lipid metabolism and Alzheimer's disease:Clinical evidence,mechanistic link and therapeutic promise[J].FEBS J,2023,290(6):1420-1453.
[4] RIZZO M R,MEO I D,POLITO R,et al.Cognitive impairment and type 2 diabetes mellitus:Focus of SGLT2 inhibitors treatment[J].Pharmacological Research,2022,176:106062.
[5] JIN S,WANG J,HE Y.The brain network hub degeneration in Alzheimer's disease[J].Biophys Rep,2024,10(4):213-229.
[6] KIM B,ELZINGA S E,HENN R E,et al.The effects of insulin and insulin-like growth factor I on amyloid precursor protein phosphorylation in in vitro and in vivo models of Alzheimer's disease[J].Neurobiol Dis,2019,132:104541.
[7] 曾龙海,卜路芳,熊艳,等.阿尔茨海默病和2型糖尿病共同发病机制和干预措施的研究进展[J].中风与神经疾病杂志,2024,41(8):692-697.
[8] WANG J,HO L,QIN W,et al.Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease[J].FASEB J,2005,19(6):659-661.
[9] GMEZ-GUIJARRO M D,ÁLVAREZ-BUENO C,SAZ-LARA A,et al.Association between severe hypoglycaemia and risk of dementia in patients with type 2 diabetes mellitus:A systematic review and meta-analysis[J].Diabetes Metab Res Rev,2023,39(3):e3610.
[10] STARKS E J,PATRICK O'GRADY J,HOSCHEIDT SM,et al.Insulin resistance is associated with higher cerebrospinal fluid tau levels in asymptomatic APOE4 carriers[J].J Alzheimers Dis,2015,46(2):525-533.
[11] TRUJILLO-ESTRADA L,NGUYEN C,DA CUNHA C,et al.Tau underlies synaptic and cognitive deficits for type 1,but not type 2 diabetes mouse models[J].Aging Cell,2019,18(3):e12919.
[12] HOBDAY A L,PARMAR M S.The link between diabetes mellitus and tau hyperphosphorylation:Implications for risk of Alzheimer's disease[J].Cureus,2021,13(9):e18362.
[13] BOYANOVA S T,LLOYD-MORRIS E,CORPE C,et al.Interaction of amisulpride with GLUT1 at the blood-brain barrier.Relevance to Alzheimer's disease[J].PLoS One,2023,18(10):e0286278.
[14] LEE A,KONDAPALLI C,VIRGA D M,et al.Aβ42 oligomers trigger synaptic loss through CAMKK2-AMPK-dependent effectors coordinating mitochondrial fission and mitophagy[J].Nat Commun,2022,13(1):4444.
[15] HENEKA M T,FINK A,DOBLHAMMER G.Effect of pioglitazone medication on the incidence of dementia[J].Ann Neurol,2015,78(2):284-294.
[16] DARST B F,HUO Z,JONAITIS E M,at al.Metabolites associated with early cognitive changes implicated in Alzheimer's disease[J].J Alzheimers Dis,2021,79(3):1041-1054.
[17] PARK Y H,SHIN S J,KIM H S,et al.Omega-3 Fatty Acid-Type docosahexaenoic acid protects against Aβ-mediated mitochondrial deficits and pathomechanisms in Alzheimer's disease-related animal model[J].Int J Mol Sci,2020,21(11):3879.
[18] BAI Y R,WANG Y Y,MENG D L,et al.Alterations of fatty acid composition and metabolism in APP/PS1 transgenic mice[J].Neurosci Lett,2020,738:135401.
[19] NIEWEG K,SCHALLER H,PFRIEGER F W.Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats[J].J Neurochem,2009,109(1):125-134.
[20] REED B,VILLENEUVE S,MACK W,et al.Associations between serum cholesterol levels and cerebral amyloidosis[J].JAMA Neurol,2014,71(2):195-200.
[21] POPP J,LEWCZUK P,KÖLSCH H,et al.Cholesterol metabolism is associated with soluble amyloid precursor protein production in Alzheimer's disease[J].J Neurochem,2012,123(2):310-316.
[22] CAO Y,ZHAO L W,CHEN Z X,et al.New insights in lipid metabolism:Potential therapeutic targets for the treatment of Alzheimer's disease[J].Front Neurosci,2024,18:1430465.
[23] HARVEY J.Novel Leptin-based therapeutic strategies to limit synaptic dysfunction in Alzheimer's disease[J].Int J Mol Sci,2024,25(13):7352.
[24] GROSBELLET E,DUMONT S,SCHUSTER-KLEIN C,et al.Leptin modulates the daily rhythmicity of blood glucose[J].Chronobiol Int,2015,32(5):637-649.
[25] HAMILTON K,HARVEY J.The neuronal actions of leptin and the implications for treating Alzheimer's disease[J].Pharmaceuticals(Basel),2021,14(1):52.
[26] GRECO S J,SARKAR S,CASADESUS G,et al.Leptin inhibits glycogen synthase kinase-3beta to prevent tau phosphorylation in neuronal cells[J].Neurosci Lett,2009,455(3):191-194.
[27] RAN T T T,CORSINI S,KELLINGRAY L,et al.APOE genotype influences the gut microbiome structure and function in humans and mice:Relevance for Alzheimer's disease pathophysiology[J].FASEB J,2019,33(7):8221-8231.
[28] 杨洋,杜丽娟,崔燕燕,等.基于肠道菌群防治2型糖尿病伴抑郁、焦虑研究进展[J].陕西医学杂志,2024,53(9):1294-1297.
[29] CUTLER H B,MADSEN S,MASSON S W C,et al.Dual Tracer test to measure tissue-specific insulin action in individual mice identifies in vivo insulin resistance without fasting hyperinsulinemia[J].Diabetes,2024,73(3):359-373.
[30] SOUDERS C L N D,ARISTIZABAL-HENAO J J,PATUEL S J,et al.Interaction between butyrate and tumor necrosis factor α in primary rat colonocytes[J].Biomolecules,2023,13(2):258.
[31] LI Z,YI C X,KATIRAEI S,et al.Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit[J].Gut,2018,67(7):1269-1279.
[32] SAKAKIBARA S,YAMAUCHI T,OSHIMA Y,et al.Acetic acid activates hepatic AMPK and reduces hyperglycemia in diabetic KK-A(y)mice[J].Biochem Biophys Res Commun,2006,344(2):597-604.
[33] WU L,HAN Y,ZHENG Z,et al.Altered gut microbial metabolites in amnestic mild cognitive impairment and Alzheimer's disease:Signals in host-microbe interplay[J].Nutrients,2021,13(1):228.
[34] MOU Y,DU Y,ZHOU L,et al.Gut Microbiota interact with the brain through systemic chronic inflammation:Implications on neuroinflammation,neurodegeneration,and aging[J].Front Immunol,2022,13:796288.
[35] GASALY N,DE VOS P,HERMOSO M A.Impact of bacterial metabolites on gut barrier function and host immunity:A focus on bacterial metabolism and its relevance for intestinal inflammation[J].Front Immunol,2021,12:658354.
[36] PARSÉUS A,SOMMER N,SOMMER F,et al.Microbiota-induced obesity requires farnesoid X receptor[J].Gut,2017,66(3):429-437.
[37] 李正民,李江静,庄莹莹,等.益生菌对脂多糖诱发大鼠脑内神经炎症及认知功能障碍保护作用的实验研究[J].陕西医学杂志,2021,50(7):771-775.
[38] 廉永琪,朱淑芬.脓毒症相关肠道微生态作用机制研究进展[J].陕西医学杂志,2024,53(12):1721-1725.
[39] ZHANG P P,LI L L,HAN X,et al.Fecal microbiota transplantation improves metabolism and gut microbiome composition in db/db mice[J].Acta Pharmacol Sin,2020,41(5):678-685.
[40] SUN J,XU J,LING Y,et al.Fecal microbiota transplantation alleviated Alzheimer's disease-like pathogenesis in APP/PS1 transgenic mice[J].Transl Psychiatry,2019,9(1):189.
[41] HAZAN S.Rapid improvement in Alzheimer's disease symptoms following fecal microbiota transplantation:A case report[J].J Int Med Res,2020,48(6):300060520925930.

相似文献/References:

[1]邓春颖,李海滨,毛文静,等.丁苯酞对阿尔茨海默病模型大鼠海马CA1 区脑源性神经营养因子和碱性成纤维生长因子蛋白表达影响的实验研究*[J].陕西医学杂志,2020,49(4):405.
　DENG Chunying,LI Haibin,MAO Wenjing,et al.Effect of dl-3-n-butylphthalide on the expression of BDNF and bFGF in CA1 region of hippocampus of Alzheimer disease rats[J].,2020,49(4):405.
[2]程 艳,郭建伟,李 扬,等.超氧化物歧化酶融合蛋白改善阿尔茨海默病小鼠大脑白质超微结构实验研究[J].陕西医学杂志,2022,51(9):1049.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.002]
　CHENG Yan,GUO Jianwei,LI Yang,et al.Experimental study of superoxide dismutase fusion protein improving ultrastructure of cerebral white matter in mice with Alzheimer's disease[J].,2022,51(4):1049.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.002]
[3]王 坤,张宸豪,荣萌萌,等.阿尔茨海默病患者血清三磷酸腺苷结合盒转运蛋白7、基质金属蛋白酶9、脂联素水平与认知功能相关性分析[J].陕西医学杂志,2024,(10):1387.[doi:DOI:10.3969/j.issn.1000-7377.2024.10.019]
　WANG Kun,ZHANG Chenhao,RONG Mengmeng,et al.Correlation between serum ABCA7,MMP-9,ADPN levels and cognitive function in patients with Alzheimer's disease[J].,2024,(4):1387.[doi:DOI:10.3969/j.issn.1000-7377.2024.10.019]

备注/Memo

备注/Memo:
[基金项目]国家自然科学基金资助面上项目(82074503); “陕西中医药大学神经退行性疾病中医药防治研究学科创新团队”项目(2019-QN05); 陕西省“特支计划”科技创新领军人才项目(陕组通字[2018]33号)
更新日期/Last Update: 2025-04-07